Understanding Pharmaceutical Sustainable Supply chains - A Case Study Application
Abstract
Keywords
References
ABBOUD, L.; HENSLYE, S. (2003). New prescription for drug makers: Update the Plant, The Wall Street Journal, September 3.
ALMOR, T.; TARBA, S.; BENJAMIN, H. (2009). Unmasking integration challenges: The case of Biogal’s acquisition by Teva Pharmaceutical Industries, International Studies of Management and Challenges, v. 39, n. 3, Fall 2009, p. 32-52
AUTRY, C. (2005). Formalization of reverse logistics programs: A strategy for managing liberalized returns, International Marketing Management, v. 34, p. 749-757
AVELLANET, J. (2010). John Avellanet on holistic pharma compliance and quality, June 2010, Available at: http://www.pharmaqbd.com
BIEDERMAN, D. (2010), Speeding Up, in Reverse, Journal of Commerce, New York.
BLACKBURN, J.; GUIDE, J.; DOUZA, G.; VAN WASSENHONE, L. (2004). “Reverse supply chains for commercial returns”, California Management Review, v. 46, n. 2, p. 6-22
BOWERSOX, D.; CLOSS, D. (1996). Logistical management: The integrated supply chain process, McGraw-Hill International Editions, London
BOWMAN, C.; AMBROSINI, V. (2000). Value creation versus value capture: towards a coherent definition of value integrity, British Journal of Management, v. 11, p. 1-15
CAMPBELL, J. (2007). Why Would Corporations Behave in Socially Responsible Ways? An Institutional Theory of Corporate Social Responsibility, Academy f Management Review, v. 32, n. 3, p. 946-967
CHEAH. E.; CHAN, W.; CHIENG, C. (2007). The corporate social responsibility of pharmaceutical product recalls: An empirical examination of US and UK markets, Journal of Business Ethics, v. 76, p. 427-449
CHASE, R. B. (1998). Operations Management Internationalization and Interdisciplinary Integration, International Journal of Operations & Production Management, v. 18, n. 7, p. 663-667
CNNMONEY.COM (2010), Drug Recalls Surge, Available at: www.cnn.com/2010/08/16/news/companies/drug_recall_surge/index.htm.
DALE, B. (2003). Managing Quality, 4th ed. Blackwell Publishing, Oxford
DE LA FUENTE, M. V.; ROS, L.; CARDÓS, M. (2008). Integrating Forward and Reverse Supply Chains: Application to a Metal-Mechanic Company, International Journal of Production Economics, v. 111, p. 782-792.
EDWARDS, A. (2010). Manufacturing the future, Integrated collaboration between CMOs and Sponsors, Available at: www.contractpharma.com/articles/2010/05/manufacturing-the-future
EISENHARDT, K. (1989). Building Theories from Case Study Research, Academy of Management Review, v. 14, n. 4, p. 532-550
EUROPEAN MEDICINES AGENCY (2007). An Analysis of Quality Product Defects in Centralized Procedure, Available at: http://www.ema.europa.eu
FASSOULA, E. (2005). Reverse logistics as a means of reducing the cost of quality, Total Quality Management & Business Excellence, v. 16, n. 5, p. 631-643
FOOD AND DRUG ADMINISTRATION, (2007). CDER Facts and Figures, Available at: http://www.fda.gov/Drugs/DrugSafety/default.htm
GOULDING, C. (2002). Grounded Theory, A Practical Guide Management. Business and Marketing Research, Sage Publications
GRAUNAUER, T.; SCHERRER-RATHJE, M.; FRIEDLI, T. (2009). A reference framework to sustainably implement operational excellence in the pharmaceutical industry, EurOMA 2009 Proceedings. Available at: www.euroma2009.org/Proceedings
GRI, (2011). Available at www.globalreporing.org
GRONROOS, C. (2008). Service logistics revisited: who creates value and who co-creates, European Business Review, v. 20, n. 4, p. 298-314
HART, S. (1997). Beyond greening, Harvard Business Review, n. 1, p. 66-76
HART, S.; MILSTEIN, M. (2003). Creating Sustainable Value, Academy of Management Executive, v. 17, n. 2, p. 55-69
HOWARD, I.; HUMBY, S. (2008). Embedding Corporate Responsibility into Supply: A Snapshot of Progress, European Management Journal, v. 26, p. 166-174
HUNTER, T. S.; DROEGE, M.; MARSH, W. A.; DROEGE, W. L. (2005). CE: Effectively managing pharmaceutical returns and waste, Drug Topics, v. 149, n. 2, p. 36.
IMS HEALTH, (2010). Available at: http://www.imshealth.com/portal/site/imshealth
INTERNATIONAL CONFERENCE ON HARMONIZATION: Available at: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html
JORGENSEN, T. (2008). Towards more Sustainable Management Systems: through Life Cycle Management and Integration, Journal of Cleaner Production, v. 16, p. 1071-1080
KIRIDERA, S.; HASAN, M.; KERR, R. (2009). Exploring deeper Structures in Manufacturing Strategy formation Progress: A Qualitative Inquiry, International Journal of Operations & Production Management, v. 29, n. 4, p. 386-417
KUMAR, S.; DIEVENEY, E.; DIEVENEY, A. (2009). Reverse logistic process control measures for the pharmaceutical supply chain, International Journal of Productivity and Performance Management, v. 58, n. 2, p. 188-204
KUMAR, S.; PUTMAN, V. (2008). Cradle to cradle: reverse logistics and opportunities across three industry sectors, Int. Journal of Production Economics, v. 115, p. 305-315
KRUMWIEDE, D.; SHEU, C. (2002). A model for reverse logistics entry by third-party providers, Omega, v. 30, p. 325-333
LEVIS, A.; PAPAGEORGIOU, L. (2004). A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry, Computers and Chemical Engineering, v. 28, p. 707-725
LINTON, J.; KLASSEN, R.; JAYARAM, V. (2007). Sustainable Supply Chains: An Introduction, Journal of Operations Management, v. 25, p. 1075-1082.
MAHBOUBIAN-JONES, G. (2009). Toyota and lesson for pharma top managers, Available at: http://www.pharmaqbd.com
MAHLER, D. (2007). The Sustainable Supply Chain, Supply Chain Management Review, v. 11, n. 8, p. 59
MARKEY, M.; DAVIS, L. (2007). Exploring future competitive advantage through sustainable supply chains, International Journal of Physical Distribution & Logistics Management, v. 37, n. 9, p. 763-774
MCCONNELL, J.; NUNNALLY, B. K.; MCGARVEY, B. (2009). Variation – Past, Present, and Future, Journal of Validation Technology, Spring 2009, p. 37-42.
MEREDITH, J. (1998). Building Operations Management Theory through Case and Field Research, Journal of Operations Management, v. 16, n. 4, p. 441-454
MOLLENKOPF, D.; CLOSS, D.J. (2005). The Hidden Value in Reverse Logistics, Supply Chain Management Review, (July/August), p. 34-43
MOLLENKOPF, D.; RUSSO, I.; FRANKEL, R. (2011). Creating Value through Returns Management: Exploring the market-Operations Interface, Journal of Operations Management, Article in press.
MOLLENKOPF, D.; RUSSO, I.; FRANKEL, R. (2007). The Returns Management Process in Supply Chain Strategy, International Journal of Physical Distribution & Logistics Management, v. 37, n. 7, p. 568-592.
MORHARDT, J.; BAIRD, S.; FREEMAN, K. (2002). Scoring Corporate Environmental and Sustainability using GRI 2000, ISO 14031 and Other Criteria, Corporate Social Responsibility and Environmental Management, v. 9, p. 215-333
PAPAGEORGIOU, L.; ROTSTEIN, G.; SHAH, N. (2001). Strategic supply chain optimization of the pharmaceutical industries, Ind. Eng. Chem. Resources, v. 40, p. 275-286
PHARMACEUTICAL MARKET TRENDS, 2010-2014 (2010). http://www.pharmaceuticalmarketresearch.com/publications/general_industry/pharmaceutical_market_trends_2008_2012.html
PLUTA, P.; POSKA, R. (2010). Compliance by Design (CbD) and Compliance Master Plan (CMP) – An Organized Approach to Compliance, Journal of GXP Compliance, v. 14, n. 2, p. 73-82
PORTER, M. (1998). Competitive Advantage: Creating and Sustaining Superior Performance, The Free Press, New York
REUTERS ONLINE, (2009). CBR Pharma Insights: The New Pharmaceutical Sales Force - Key Trends Shaping Future Sales Strategies, Available at: http://www.reuters.com/article/pressRelease/idUS116884+06-Apr
+BW20090406
RITCHIE, L.; BURNES, B.; WHITTLE, P.; HEY, R. (2000). The benefits of reverse logistics: the case of Manchester Royal Infirmary Pharmacy, Supply Chain Management, v. 5, p. 226-34.
SARTORI, G. (2011). Reverse logistics role in securing pharmaceutical supply chain, Reverse Logistics Magazine, Edition 16
SKINNER, L. R.; BRYANT, P. T.; RICHEY R. G. (2008), Examining the Impact of Reverse Logistics Disposition Strategies, International Journal of Physical Distribution & Logistics Management, v. 38, n. 7, p. 518-539.
SOUZA, D.; DANASE, J.; CONSTATINOU, D. (2005). Business Efficiency and Regulatory.
SOUZA, A.; KEELING, D.; PHILLIPS, R. (2007). Improving quality in pharma manufacturing, The McKinsey Quarterly
STEGEMANN, S. (2010). Better by design, Available at http://www.worldpharmaceuticals.net/editorials/017march10/WPF017_better-by-design.pdf
STOCK, J. R. (1998). Development and Implementation of Reverse Logistics Programs, Council of Logistics Management, Annual Conference Proceeding
STOCK, J.; MULKI, J. (2009). Product returns processing: an examination of practices of manufacturers, wholesalers/distributors, and retailers, Journal of Business Logistics, v. 30, n. 1, p. 33-62
STRAUS, A. L.; CORBIN, J. (1994), Grounded Theory Methodology: An Overview, in Denzin Denzin, Norman K. (ed.) Handbook of Qualitative Resarch, London; Sage p. 273-285
SUDDABY, R. (2006). What Grounded Theory is Not, Academy Management Journal, v. 49, n. 4, p. 633-642
SZÉKELY, F.; KNIRSCH, M. (2005). Responsible Leadership and Corporate Social Responsibility: Metrics for Sustainable Performance, European Management Journal, v. 23, n. 6, p. 628-647
TRIM, P.; LEE, Y. (2004). A Reflection on Theory building and Development of Management Knowledge, Management Decision, v. 42, n. 314, p.473-480
YIN, R. (1994). Case Study Research: Design and Methods, Sage, London
YIN, R. (2009). Case Study Research: Design and Methods, Sage, London
YU, L. (2008). Pharmaceutical quality by Design: Product and Process Development, Understanding, and Control, Pharmaceutical Research, v. 25, n. 4.
VELEVA, V.; ELLENBECKER, M. (2001). Indicators of Sustainable Production: Framework and Methodology, Journal of Cleaner Production, v. 9, n. 6, p. 519-49
DOI: http://dx.doi.org/10.14807/ijmp.v4i1.72
Article Metrics
Metrics powered by PLOS ALM
Refbacks
- There are currently no refbacks.
Copyright (c)
| LIBRARIES BY | ||||
| | | | |
| | | | |
| | | | |
